Sign Up Today and Learn More About Photys Therapeutics Stock
Invest in or calculate the value of your shares in Photys Therapeutics or other pre-IPO companies through EquityZen's platform.
Photys Therapeutics Stock (PHTH)
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
About Photys Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Science and Engineering, Biotechnology
Photys Therapeutics Press Mentions
Stay in the know about the latest news on Photys Therapeutics
Photys Therapeutics’ $186 Million Research Collaboration with Novo Nordisk
globallegalchronicle • Dec 23, 2024
Novo Nordisk links up with Photys Thera on cardiometabolic targets
thepharmaletter • Dec 19, 2024
Photys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic Diseases
globenewswire • Dec 18, 2024
Photys Therapeutics Announces Research Collaboration with Novo Nordisk to Develop Induced Proximity PHICS Technology for Cardiometabolic Diseases
morningstar • Dec 18, 2024
Novo Nordisk taps Photys for $186M cardiometabolic collab
fiercebiotech • Dec 18, 2024
Photys Therapeutics Management
Leadership team at Photys Therapeutics
Board of Directors
Lizzie Ngo
Board of Directors
Otello Stampacchia
Join now and verify your accreditation status to gain access to:
- Photys Therapeutics current valuation
- Photys Therapeutics stock price
- Available deals in Photys Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Photys Therapeutics Stock
How to invest in Photys Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Photys Therapeutics through EquityZen funds. These investments are made available by existing Photys Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Photys Therapeutics stock?
Shareholders can sell their Photys Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
